Researcher
Philippe Gevaert
- Disciplines:Allergology, Otorhinolaryngology not elsewhere classified, Rhinology, Sleep medicine, Applied immunology, Immunology not elsewhere classified, Adaptive immunology
Affiliations
- Department of Head and Skin (Department)
Member
From1 Oct 2018 → Today - Department of Otorhinolaryngology (Department)
Responsible
From1 Feb 2014 → 30 Sep 2018 - Department of Otorhinolaryngology (Department)
Member
From1 Feb 2014 → 30 Sep 2018 - Department of Otorhinolaryngology (Department)
Member
From1 Oct 1998 → 30 Sep 2018
Projects
1 - 5 of 5
- The who, where and when of airway immunoglobulins: dissecting the mechanisms leading to local modulation of allergic airway disease.From1 Nov 2022 → TodayFunding: FWO fellowships
- An integrated approach to unravel eosinophil function in chronic eosinophilic disordersFrom1 Jan 2022 → TodayFunding: FWO EOS
- Understanding the division of labour between local and systemic humoral responses in allergic airway disease.From1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- CHITINAIR: the role of CHItinases and chitinase like proteins in human Type 2 INflammatory AIRway diseasesFrom1 Nov 2019 → 31 Oct 2023Funding: FWO fellowships
- Diagnostic and therapeutic consequences of mucosal lymphoid accumulation and local IgE in the noseFrom1 Feb 2010 → 30 Sep 2015Funding: BOF - Doctoral projects
Publications
21 - 30 of 51
- Efficacy of a 300IR house dust mite tablet is consistent when evaluated by the proportion of symptom-controlled days: Results of a large randomised, double-blind placebo-controlled, multicentre trial(2019)Volume: 74
Authors: P. Demoly, P. Creticos, Philippe Gevaert, F. De Blay, K. Kowal, M. Le Gall, N. Nenasheva, G. Passalacqua, O. Pfaar, M. Tortajada-Girbes, et al.
Pages: 338 - 338 - Mite immunotherapy with Alutard SQ 510 induces an incomplete protective antibody response(2019)Volume: 49
Authors: Rodriguez A. Dominguez, Margot Berings, A. Rohrbach, H. -J. Huang, Philippe Gevaert, P. M. Matricardi, R. Valenta, S. Vrtala
Pages: 736 - 736 - Baseline characteristics of phase 3 randomized controlled trials of omalizumab in chronic rhinosinusitis with nasal polyps(2019)Volume: 74
Authors: Claus Bachert, Philippe Gevaert, J Corren, J Mullol, J Han, R Ow, I Hussain, L Islam, R Fogel, D Kaufman, et al.
Pages: 329 - 330 - Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium : a BelSACI-Abeforcal-EUFOREA statement(2019)
Authors: PW Hellings, B Pugin, G Mariën, Claus Bachert, C Breynaert, DM Bullens, JL Ceuppens, G Clement, T Cox, D Ebo, et al.
- 'Blockers' can benefit from 300IR house dust mite tablet-results of a large multicentre clinical trial in house dust mite induced allergic rhinitis patients(2019)Volume: 74
Authors: P. Demoly, P. Creticos, F. De Blay, Philippe Gevaert, K. Kowal, M. Le Gall, N. Nenasheva, G. Passalacqua, O. Pfaar, M. Tortajada-Girbes, et al.
Pages: 906 - 907 - ARIA masterclass 2018 : from guidelines to real-life implementation(2019)
Authors: Peter W. Hellings, Sven F. Seys, Gert Marien, Ioana Agache, Walter Canonica, Philippe Gevaert, Tari Haahtela, Ludger Klimek, Joaquim Mullol, Oliver Pfaar, et al.
Pages: 392 - 399 - Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis(2019)
Authors: Lien Calus, Nicholas Van Bruaene, Cédric Bosteels, Sarah Dejonckheere, Thibaut Van Zele, Gabriële Holtappels, Claus Bachert, Philippe Gevaert
- EPOS2020 : development strategy and goals for the latest European Position Paper on Rhinosinusitis(2019)
Authors: Wytske Fokkens, Martin Desrosiers, Richard Harvey, Claire Hopkins, Joaquim Mullol, Carl Philpott, Isam Alobid, Wilma Terezinha Anselmo-Lima, Claus Bachert, Fuad Baroody, et al.
Pages: 162 - 168 - Efficacy and safety of the 300 IR sublingual tablet for the treatment of house dust mite-associated allergic rhinitis : a multicentre, international, dbpc, randomized phase III clinical trial(2019)Volume: 74
Authors: P. Demoly, J. Corren, P. Creticos, F. De Blay, I Douville, Philippe Gevaert, Peter Hellings, S. Khairallah, K. Kowal, M. Le Gall, et al.
Pages: 14 - 14 - Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32(2018)
Authors: Verena Niederberger, Angela Neubauer, Philippe Gevaert, Mihaela Zidarn, Margitta Worm, Werner Aberer, Hans Jørgen Malling, Oliver Pfaar, Ludger Klimek, Wolfgang Pfützner, et al.
Pages: 497 - 509